Lantus and Combigan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lantus (insulin glargine recombinant) and Combigan (brimonidine tartrate; timolol maleate). Common drug interactions include coronary artery disease among females and fatigue among males.
The phase IV clinical study analyzes what interactions people have when they take Lantus and Combigan. It is created by eHealthMe based on reports of 221 people who take the same drugs from the FDA, and is updated regularly.
What is Lantus?
Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.
What is Combigan?
Combigan has active ingredients of brimonidine tartrate; timolol maleate. It is often used in glaucoma. eHealthMe is studying from 7,810 Combigan users. Check the latest studies of Combigan.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
221 people who take Lantus and Combigan together, and have interactions are studied.
What are the common drug interactions of Lantus and Combigan, by gender? *
What are the common drug interactions of Lantus and Combigan, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Lantus and Combigan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lantus and Combigan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lantus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Combigan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lantus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Combigan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on insulin glargine recombinant and brimonidine tartrate; timolol maleate (the active ingredients of Lantus and Combigan, respectively), and Lantus and Combigan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Synthroid cause Urination - Excessive At Night? - now
- How effective is Monodox for Acne? - 2 seconds ago
- Could Ibuprofen cause Synovial Cyst? - 2 seconds ago
- Cozaar and Intervertebral Disc Protrusion for Women aged 60+ - 15 seconds ago
- Drug interactions of Contrave and Ativan - 19 seconds ago
- Could Sancuso cause Nausea And Vomiting? - 22 seconds ago
- Drug interactions of Depakote and Norvir - 24 seconds ago
- Keytruda and Dyspnoea Exacerbated for Men aged 40-49 - 27 seconds ago
- Keytruda and Dyspnea Exacerbated for Men aged 40-49 - 28 seconds ago
- Drug interactions of Tylenol W/ Codeine and Zelnorm - 30 seconds ago